Dimensional Fund Advisors
VOR icon

Dimensional Fund Advisors’s Vor Biopharma VOR Stock Holding History

Dimensional Fund Advisors’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,211
Closed -$17K – 3364
2024
Q3 		$17K Hold
1,211
– – ﹤0.01% 3341
2024
Q2 		$24.2K Sell
1,211
-35
-3% -$1.13K ﹤0.01% 3344
2024
Q1 		$59.1K Buy
1,246
+222
+22% +$9.75K ﹤0.01% 3323
2023
Q4 		$46.1K Sell
1,024
-561
-35% -$23.2K ﹤0.01% 3355
2023
Q3 		$67.2K Sell
1,585
-1,054
-40% -$57.1K ﹤0.01% 3358
2023
Q2 		$163K Buy
2,639
+495
+23% +$45.2K ﹤0.01% 3269
2023
Q1 		$231K Buy
2,144
+70
+3% +$7.76K ﹤0.01% 3176
2022
Q4 		$276 Buy
2,074
+427
+26% +$42.3K ﹤0.01% 3161
2022
Q3 		$131K Buy
+1,647
New +$162K ﹤0.01% 3303

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's VOR Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Vor Biopharma (VOR) in Q4 2024, closing a stake of 1,211 shares — an estimated $17K sold.

Dimensional Fund Advisors first reported a position in VOR in Q3 2022 and held it in 9 quarters. The position peaked at $231K in Q1 2023. 50 funds tracked by Wall St. Rank hold VOR as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Vor Biopharma position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,211 Vor Biopharma shares in Q4 2024, an estimated $17K.
  • Dimensional Fund Advisors first reported a position in Vor Biopharma in Q3 2022 and held it in 9 quarters.
  • Dimensional Fund Advisors's Vor Biopharma position peaked at $231K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.